Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

News | Stents

FDA Class 1 Recall on iCast Stent for Separation Risk That May Cause Harm

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the iCa ...

June 02, 2022

Dr. Jeff Healey is seen implanting a subcutaneous defibrillator in a patient at the Electrophysiology Lab. Image credit: Owen Thomas, Hamilton Health Sciences.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 10 Most-read Content for May

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...

June 01, 2022

Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions

News | Cardiovascular Clinical Studies

Biofourmis Selected by ACC as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study

June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...

June 01, 2022

Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Low Glycaemic Index Diet Helps Heart Patients Lose Weight

June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...

June 01, 2022

Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction

News | Cardiogenic Shock

Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design

June 1, 2022 — Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin ...

June 01, 2022

COMPASS open label extension study results support the long-term use of XARELTO plus aspirin for vascular protection in patients with chronic CAD and/or PAD

News | Cardiovascular Clinical Studies

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...

May 31, 2022

First clinical data of implantable heart sensor with remote measurement capabilities presented at prestigious Late-Breaking Science forum at the ESC Heart Failure 2022

News | Heart Failure

VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure

May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...

May 31, 2022

The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has identified this as a Class I recall, the most serious type of recall.

News | Cath Lab

Abbott Medical Recalls Dragonfly OpStar Imaging Catheter for Potential Loose Catheter Marker Band

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

May 26, 2022

Late-breaking results presented at the European Society of Cardiology's Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart Failure

News | Heart Failure

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

May 26, 2022 — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced ...

May 26, 2022

The study found a gene called FMNL2 links cerebrovascular disease and Alzheimer’s and suggests changes in FMNL2 activity caused by cerebrovascular disease prevent the efficient clearance of toxic proteins from the brain, eventually leading to Alzheimer’s disease.

News | Cardiovascular Clinical Studies

Missing Link Between Alzheimer's and Vascular Disease Found?

May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...

May 26, 2022

Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to a study from Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg Cardiovascular Research Institute.

News | Heart Failure

New Research Reveals How the Heart Repairs After a Heart Attack

May 25, 2022 — Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to ...

May 25, 2022

A section of a normal healthy heart (left) and three locations in a heart from a patient with arrhythmogenic cardiomyopathy. There are a lot more fat cells (large while spheres) in the diseased heart. Cardiomyocytes in the composite region often show signs of degeneration, as well as enhanced ZBTB11 expression

News | Cardiovascular Clinical Studies

New Gene Identified in Arrhythmogenic Cardiomyopathy

May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...

May 25, 2022

The ŌNŌ is intended to simplify bailout procedures in the expanding world of structural heart disease interventions

News | Structural Heart

ŌNŌCOR Receives FDA Clearance for Novel Endovascular Retrieval Technology

May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food ...

May 25, 2022

News | Cardiovascular Business

Thomas E. MacGillivray Named Chair of Cardiac Surgery for MedStar Heart & Vascular Institute

May 25, 2022 — MedStar Heart & Vascular Institute announced that Thomas E. MacGillivray, MD, has been named physician ...

May 25, 2022

Amarin Corporation plc announced that research on the potential population health impact and cost-effectiveness of VASCEPA (icosapent ethyl), presented in two poster presentations at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions in Reston, VA, May 13-14, 2022

News | Pharmaceuticals

Research Presented at AHA's QCOR Scientific Sessions Indicate Potential for Vascepa to Reduce Major Adverse CV Events

May 24, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...

May 24, 2022